新型冠状病毒肺炎疫情期间慢性阻塞性肺疾病稳定期患者的中医预防  

Traditional Chinese medicine prevention of patients with stable chronic obstructive pulmonary disease during COVID-19 epidemic period disease

作　　者：刘惠梅 高峰[1] Liu Huimei;Gao Feng

机构地区：[1]中国中医科学院望京医院,北京100102

出　　处：《中医临床研究》2020年第33期38-39,111,共3页Clinical Journal Of Chinese Medicine

摘　　要：自2019年12月底以来,新型冠状病毒肺炎(Corona Virus Disease 2019,COVID-19)(简称新冠肺炎),在全国范围内蔓延。在新型冠状病毒肺炎疫情防控期间,慢性阻塞性肺疾病(慢阻肺)的患者抵抗力差,是疫情防治的重点对象,而中国慢阻肺患者接近1亿人。根据中医学“治未病”的防病理念进行精细化和个体化的患者管理,避免慢阻肺稳定期患者急性发作,有效防范新冠肺炎,具有十分重要的意义。Since the end of December 2019,corona virus disease 2019(COVID-19),as a novel infectious disease,has rapidly spread throughout the country.During the period of prevention and control,patients with chronic obstructive pulmonary disease(COPD)have poor resistance,which is the key object of epidemic prevention and control,but the number of patients with COPD in China is close to 100 million.Therefore,meticulous and individualized patient management should be carried out according to the prevention concept of"Disease prevention"in traditional Chinese medicine,which can avoid acute exacerbation,prevent COVID-19 effectively and is of great significance.

关 键 词：慢性阻塞性肺疾病 新型冠状病毒肺炎 中医预防 

分 类 号：R512.99[医药卫生—内科学]